Patents by Inventor Clark Colledge

Clark Colledge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gamma-conopeptides
    Publication number: 20060223984
    Abstract: This invention relates to relatively short peptides about 25-40 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogs to the naturally available peptides, and which include three cyclizing disulfide linkages and one or more ?carboxyglutamate residues.
    Type: Application
    Filed: August 26, 2003
    Publication date: October 5, 2006
    Applicants: Cognetix Inc., University of Utah Research Foundation
    Inventors: Michael Fainzilber, Karel Kits, Alma Burlingame, Baldomero Olivera, Craig Walker, Maren Watkins, Reshma Shetty, Lourdes Cruz, Julita Imperial, Clark Colledge
  • Conantokins
    Publication number: 20030194729
    Abstract: The present invention is directed to conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more &ggr;-carboxyglutamic acid residues. The contantokins are useful for the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, neuroprotective agents or analgesic agents.
    Type: Application
    Filed: February 4, 2003
    Publication date: October 16, 2003
    Inventors: Fe C. Abogadie, Lourdes J. Cruz, Baldomero M. Olivera, Craig Walker, Clark Colledge, David R. Hillyard, Elsie Jimenez
  • Gamma-conopeptides
    Patent number: 6624288
    Abstract: This invention relates to relatively short peptides about 25-40 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogs to the naturally available peptides, and which include three cyclizing disulfide linkages and one or more &ggr;-carboxyglutamate residues.
    Type: Grant
    Filed: December 15, 1998
    Date of Patent: September 23, 2003
    Assignees: Cognetix, Inc., University of Utah Research Foundation
    Inventors: Michael Fainzilber, Karel S. Kits, Alma L. Burlingame, Baldomero M. Olivera, Craig Walker, Maren Watkins, Reshma Shetty, Lourdes J. Cruz, Julita Imperial, Clark Colledge
  • Conantokins
    Patent number: 6515103
    Abstract: The present invention is directed to conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more &ggr;-carboxyglutamic acid residues. The conantokins are useful for the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, neuroprotective agents or analgesic agents.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: February 4, 2003
    Assignees: University of Utah Research Foundation, Cognetix, Inc., Salk Institute
    Inventors: Fe C. Abogadie, Lourdes J. Cruz, Baldomero M. Olivera, Craig Walker, Clark Colledge, David R. Hillyard, Elsie Jimenez, Richard T. Layer, Li-Ming Zhou, Gregory S. Shen, R. Tyler McCabe, Jean E. Rivier